申请人:Italfarmaco S.p.A.
公开号:US06034096A1
公开(公告)日:2000-03-07
The present invention provides medicinal compounds that are characterized by a cyclic moiety (A) linked through a carboxamido group (more specifically, a carbamate group or a urea group) to another cyclic moiety (B) which is in turn linked to another, N-substituted carboxamido group. These compounds can be used an anti-inflammatory and immunosuppressive agents, as demonstrated by their inhibition of the production of IL-1.beta. in vitro and TNF.alpha. in vivo.
本发明提供了一种药物化合物,其特点是由一个环状基团(A)通过一个羧胺基团(更具体地说,是一个碳酸酯基团或脲基团)连接到另一个环状基团(B),而后者又连接到另一个N-取代羧胺基团。这些化合物可以用作抗炎和免疫抑制剂,通过它们在体外抑制IL-1β的产生和在体内抑制TNFα的表现来证明。